A practical reference on proteolysis: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-06-01 and is reviewed periodically as new material appears.
Peptide bonds are vulnerable to protease attack, and Selank is no exception. Measured half-life in serum is short, on the order of minutes in several reports, which explains why intranasal administration is the common route described in the literature. Absorption across the nasal mucosa partially bypasses first-pass hepatic metabolism. Quantitative data on human bioavailability remain limited and are difficult to compare across studies.
Lyophilised material kept dry at minus 20 degrees Celsius or colder is the most stable form, and suppliers commonly state a shelf life of two years or more under those conditions. Once dissolved, degradation accelerates through hydrolysis and deamidation, particularly at alkaline pH or elevated temperature. Working solutions are usually divided into single-use aliquots to avoid repeated freeze-thaw cycles. The choice of reconstitution solvent affects both stability and the ionic strength of the final preparation.
Measuring peptide exposure inside the brain is technically difficult. Selank is degraded rapidly in plasma, and assays must separate intact peptide from fragments, which favors targeted mass spectrometry over immunoassays alone. Reported half-lives are short, on the order of minutes, so effects observed hours later are attributed to downstream signaling rather than to the parent compound. Blood-brain barrier permeability is debated and rarely quantified directly. Gaps include absent dose-response characterization, inconsistent reporting of purity, and almost no pharmacokinetic data from human participants.
Selank is studied chiefly as an animal-model anxiolytic with proposed secondary effects on memory and immune signaling. Reported mechanisms include modulation of the GABA-A receptor complex, inhibition of enkephalin-degrading enzymes, and shifts in monoamine turnover within limbic structures. Some experiments describe increased expression of brain-derived neurotrophic factor in the hippocampus after repeated dosing. No single molecular target has been confirmed, and the peptide does not bind any receptor with the selectivity typical of a conventional small-molecule drug. Mechanism therefore remains a set of hypotheses rather than an established pathway.
Laboratory work relies on standard behavioral paradigms. Rodents are tested in the elevated plus maze, open field, and passive avoidance tasks, with outcomes compared against diazepam or vehicle controls. Intranasal dosing is used most often because it bypasses first-pass metabolism, though intraperitoneal and intravenous routes also appear in published protocols. Biochemical endpoints include tissue BDNF concentrations, cytokine levels, and monoamine metabolites. Human data are limited to small Russian trials reporting reduced anxiety scores; most were not prospectively registered, and few employed independent outcome assessment.
| Property | Value | Notes |
|---|---|---|
| Dry storage temperature | -20 C or below | Sealed, desiccated, protected from light |
| Solution stability | Hours to days at 2-8 C | Depends on buffer and microbial load |
| Preferred pH range | Near neutral to slightly acidic | Alkaline pH accelerates hydrolysis |
| Main degradation routes | Hydrolysis and deamidation | No cysteine or methionine in sequence |
| Identity confirmation | Electrospray mass spectrometry | Observed mass compared with 751.9 Da |
Proposed mechanisms centre on modulation of the GABAergic system, with reports of altered expression of genes related to GABA-A receptor subunits and changed monoamine turnover. Some studies describe inhibition of enkephalinase, the enzyme that degrades endogenous enkephalins, which may prolong opioid peptide signalling. Effects on brain-derived neurotrophic factor and on cytokine expression have also been reported. These findings come largely from animal models and small human studies, and the precise primary target remains unresolved.
Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.
Regulatory treatment varies by jurisdiction. In Russia the compound is a registered prescription product, while in the European Union and the United States it is generally handled as a research chemical without a marketing authorization. Suppliers therefore operate outside pharmaceutical oversight, and buyers rely on supplier documentation for purity and identity claims. Chain of custody and third-party testing are the main verification tools. Analysts note that the absence of a pharmacopoeial monograph for research-grade material limits standardization across vendors.
Purity assessment relies mainly on reverse-phase high-performance liquid chromatography with ultraviolet detection. Because the peptide lacks a strong chromophore, detection often uses backbone absorbance near 214 nm. Identity is confirmed by mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, comparing the measured mass against the expected value. Amino acid analysis can verify composition after acid hydrolysis. Diastereomer content and residual counterions are reported less often, although both can influence biological assays.
David G. Armstrong (born February 18, 1969) is an American podiatric surgeon and academic known for his work in diabetic foot care, wound healing, and limb preservation. He is a Distinguished Professor of Surgery and Neurological Surgery at the University of Southern California (USC), where he directs the university's Center to Stream Healthcare in Place (C2SHiP), a National Science Foundation–funded initiative focused on advancing home-based health technologies and care models. Armstrong is the founding president of the American Limb Preservation Society (ALPS) and co-founder and co-chair of the International Diabetic Foot Conference (DFCon), the largest annual international symposium on the diabetic foot in the world. He also co-founded the Southwestern Academic Limb Salvage Alliance (SALSA) and has contributed to the development of interdisciplinary strategies for managing chronic limb-threatening ischemia and preventing diabetes-related amputations.
RNA-eIF4E complexes are never observed in PML bodies consistent with the observation that PML suppresses the m7G cap binding function of eIF4E. Structural studies show that a related arenavirus RING finger protein, Lassa Fever Z protein, can similarly bind eIF4E on the dorsal surface. eIF4E nuclear entry is mediated by its direct interactions with Importin 8 where Importin 8 associates with the m7G cap-binding site of eIF4E. Indeed, reduction in Importin 8 levels reduce the oncogenic potential of eIF4E overexpressing cells and its RNA export function. Importin 8 binds to the cap-binding site of eIF4E and is competed by excess m7G cap analogues as observed by NMR. eIF4E also stimulates the RNA export of Importin 8 RNA thereby producing more Importin 8 protein. There may be additional importins that play this role depending on cell type. Although an initial study suggested that the eIF4E transporter protein 4E-T (eIF4ENIF1) facilitated nuclear entry, later studies showed that this factor rather alters the localization of eIF4E to cytoplasmic processing bodies (P-bodies) and repress translation. Potyvirus viral protein genome linked (VPg) were found to directly bind eIF4E in its cap-binding site. VPg is covalently linked to its genomic RNA and this interaction allows VPg to act as a "cap." The potyvirus VPg has no sequence or structural homology to other VPg's such as those from poliovirus.
McCrone resigned from STURP in June 1980, after giving back all of the tape samples in his possession to Ray Rogers. John Heller and Alan Adler examined the same samples and agreed with McCrone's result that the cloth contains iron oxide. However, they argued that the exceptional purity of the chemical and comparisons with other ancient textiles showed that, while retting flax absorbs iron selectively, the iron itself was not the source of the image on the shroud. After his analysis of the Shroud was first published in 1980, McCrone continued to argue in journal articles, public lectures, and in the book Judgment Day for the Shroud of Turin (which appeared in 1996), that the Shroud had been painted in the 14th century and that it showed no traces of actual blood. He also argued that the members of STURP lacked relevant expertise in the chemical microanalysis of historical artworks and that their non-detection of pigment in the Shroud's image was "consistent with the sensitivity of the instruments and techniques they used". For his work on the Shroud, McCrone was awarded the American Chemical Society's National Award in Analytical Chemistry in 2000.
During the final stages of World War II in 1945, the United States conducted atomic raids on the Japanese cities of Hiroshima and Nagasaki, the first on August 6, 1945, and the second on August 9, 1945. These two events were the first and only times nuclear weapons have been used in combat. For six months before the atomic bombings, the U.S. 20th Air Force under General Curtis LeMay executed low-level incendiary raids against Japanese cities. The most destructive air raid to occur during the process was not the nuclear attacks, but the Operation Meetinghouse raid on Tokyo. On the night of March 9–10, 1945, Operation Meetinghouse commenced and 334 Boeing B-29 Superfortress bombers took off to raid, with 279 of them dropping 1,665 tons of incendiaries and explosives on Tokyo. The bombing was meant to burn wooden buildings and indeed the bombing caused fire that created a 50 m/s wind, which is comparable to tornadoes. Each bomber carried 6 tons of bombs. A total of 381,300 bombs, which amount to 1,783 tons of bombs, were used in the bombing. Within a few hours of the raid, it had killed an estimated 100,000 people and destroyed 41 km2 (16 sq mi) of the city and 267,000 buildings in a single night — the deadliest bombing raid in military aviation history other than the atomic raids on Hiroshima and Nagasaki. By early August 1945, an estimated 450,000 people had died as the U.S. had intensely firebombed a total of 67 Japanese cities. In late June 1945, as the U.S.
== Further reading == Hunt, Chris; et al. (August 28, 2023). "Shanidar et ses fleurs? Reflections on the palynology of the Neanderthal 'Flower Burial' hypothesis". Journal of Archaeological Science. 159 105822. Bibcode:2023JArSc.159j5822H. doi:10.1016/j.jas.2023.105822. S2CID 261325698. Pettitt, Paul; White, Mark (2012). The British Palaeolithic: hominin societies at the edge of the Pleistocene world. London: Routledge. ISBN 978-0-415-67454-6. Romagnoli, Francesca; Rivals, Florent; Benazzi, Stefano (2022). Updating Neanderthals: Understanding Behavioural Complexity in the Late Middle Palaeolithic. Academic Press. ISBN 978-0-12-821429-9. Stringer, C.; Gamble, C. (1993). In search of the Neanderthals. Thames and Hudson. ISBN 0-500-05070-8. Sykes, Rebecca Wragg (2020). Kindred: Neanderthal Life, Love, Death and Art. London: Bloomsbury Sigma. ISBN 978-1-4729-3749-0.
Sources: en.wikipedia.org
The Bateman equation predicts the relative quantities of all the isotopes that compose a given decay chain once that decay chain has proceeded long enough for some of its daughter products to have reached the stable (i.e., nonradioactive) end of the chain. A decay chain that has reached this state, which may require billions of years, is said to be in equilibrium. A sample of radioactive material in equilibrium produces a steady and steadily decreasing quantity of radioactivity as the isotopes that compose it traverse the decay chain. On the other hand, if a sample of radioactive material has been isotopically enriched, meaning that a radioisotope is present in larger quantities than would exist if a decay chain were the only cause of its presence, that sample is said to be out of equilibrium. An unintuitive consequence of this disequilibrium is that a sample of enriched material may occasionally increase in radioactivity as daughter products that are more highly radioactive than their parents accumulate. Both enriched and depleted uranium provide examples of this phenomenon.
=== Gas separation === Utilization of membranes in gas separation, like carbon dioxide (CO2), Nitrogen oxides (NOx), Sulphur oxides (SOx), harmful gasses can be removed to protect the environment. Biomass Membrane gas separation more effective than commercial membrane.
PfSSM (2008), CBM and CCF (2008) for Plasmodium proteins, which have a different amino acid evolutionary bias due to the low GC content of the genome. Matrices for transmembrane proteins. JTT transmembrane (1994) is the first of the class. Later work include: For alpha-helical transmembrane proteins, PHAT (2000) and SLIM (2001). For beta-barrel transmembrane proteins, bbTM (2008). Matrices for a specific protein family, including GPCRtm (2015) for the transmembrane (mostly helical) regions of GPCRs. Matrices for proteins with a specific role, including Hubsm (2017) for "hub proteins" in protein‐protein interaction networks. Matrices for intrinsically disordered proteins, including DUNMat (2002), MidicMat (2009), Disorder (2010), and EDSSMat (2019).
== Safety == In 2023, the European Food Safety Authority reassessed the safety of erythritol and lowered the recommended daily intake limit to 0.5 grams per kg body weight, which equates to 35 g for an average adult (70 kg). The lower limit was set to "safeguard against its laxative effect and to mitigate against long-term effects, such as electrolyte imbalance arising from prolonged exposure to erythritol-induced diarrhea." Previously, in 2015, scientists assessed doses for erythritol where symptoms of mild gastrointestinal upset occurred, such as nausea, excess flatus, abdominal bloating or pain, and stool frequency. At a content of 1.6% in beverages, it was not considered to have a laxative effect. The upper limit of tolerance was 0.78 and 0.71 g/kg body weight in adults and children respectively. In the United States, erythritol is among several sugar alcohols that are generally recognized as safe (GRAS) for food manufacturing.
Sources: en.wikipedia.org
Dry powder is best kept sealed, protected from light, and held at minus 20 degrees Celsius or below. Desiccant packaging helps limit moisture uptake because the material is hygroscopic. A sealed vial should be allowed to equilibrate to room temperature before opening to reduce condensation.
Hydrolysis of peptide bonds and deamidation of arginine and proline residues are the main degradation routes. Alkaline pH and higher temperatures accelerate both processes. Buffered, near-neutral solutions stored cold generally degrade more slowly than unbuffered ones.
Reverse-phase chromatography gives the clearest single view of related impurities and truncated sequences. Mass spectrometry then confirms that the main peak carries the expected mass. Neither test detects enantiomeric impurities, which require a separate chiral assay.
Intranasal administration predominates in both animal and human research because it avoids hepatic first-pass metabolism. Injectable and intraperitoneal routes appear in animal work mainly for comparison.